Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Winstead T, Newman A. Syringe Services Program Participants’ Perceptions, Concerns, and Experiences of Medications for Opioid Use Disorder (MOUD). Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2026
  2. Carlini BH, Williams JR, Garrett SB, Hammond D. People with psychotic disorders are the most vulnerable to cannabis adverse health outcomes: A study in WA State, USA. Community Mental Health Journal 2026;62:889-895. [doi: 10.1007/s10597-025-01579-1]
  3. Newman A, Banta-Green CJ. Safer Smoking Supplies – Use, Engagement, and Association with Decreased Injecting in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2026.
  4. Hartzler B, Brunner M, Fokuo JK, Ostacher MJ, Pagano A, Rutkowski BA, Vest RA, Masson CL. There and back again: Continuing efforts via regional partnership to promote workforce awareness of scientific advancements in addiction care. Journal of Substance Use and Addiction Treatment 2026 (in press). [doi: 10.1016/j.josat.2026.209905] PMID: 41554458
  5. Leyde S, Bell C, Harris C, Wan C, Nye E, Simon CB, Hoog J, Kennedy AJ, Hartzler B, Tsui JI, Fockele C. “It’s not a one-size-fits-all”: Patient perspectives on contingency management and community reinforcement approach for methamphetamine use disorder in permanent supportive housing. Journal of Health Care for the Poor and Underserved 2026;37(2):705-722. [doi: 10.1353/hpu.2026.a992138] PMID: 42290360
  6. Hartzler B, Peng L, Cooke A, Kunkel L, Stack E, Leahy J, Cook R, Hildebran C, Hoffman K, Verbeck J, Nugent M, Leichtling G, Smith Payne K, McIlveen JW, Korthuis PT. Reason to expand the contingency management workforce: Coaching-to-criterion results for addiction professionals and peer specialists. Substance Use & Addiction Journal 2026;47(2):541-548. [doi: 10.1177/29767342251363007] PMID: 40908764
  7. Iacobelli NP, Estrella L, Owens MD, Bhatraju EP, Gojic AJ, Kennedy D, Chander G, Tsui JI. “You’re doing it because your freedom is on the line”: a qualitative study exploring how people who use opioids and methamphetamine navigate legal involvement and carceral treatment for substance use disorder. Harm Reduction Journal 2026; 23, 30. [doi: 10.1186/s12954-025-01378-7] PMID: 41547813
  8. Salinsky LM, Diaz KC, Fox JL, Panh SM, Ferguson SM. Fentanyl, methamphetamine and polysubstance use differentially affect locomotor sensitisation and social behaviour in rats: Psychedelic treatment reverses social deficits. Addiction Biology 2026;31(3):e70132. [doi: 10.1111/adb.70132]
  9. Whiteside LK, Lovett K, Nye E, Engstrom A, Hall J, Field C, Haegerty P, Palinkas LA, McGovern M, Banta-Green CJ, Zatzick D. Emergency department longitudinal integrated care (EDLINC) study: Protocol for a pragmatic effectiveness randomized clinical trial. Contemporary Clinical Trials 2026 (in press). [doi: 10.1016/j.cct.2026.108400] PMID: 42419503
  10. Carlini BH, Kellum LB, Garrett SB, Williams JR. Cannabis-related problems, adverse events, clinical experiences and barriers to intervening: Perspectives of health care providers in Washington State. Substance Use & Addiction Journal 2026;47(3):852-863. [doi: 10.1177/29767342261426116] PMID: 41910114
  11. Janson S, Newman A, Banta-Green CJ, Glick SN, Tinsley J, Owens MD. Substance use treatment utilization and unmet demand among recently incarcerated syringe services program participants in Washington state. Harm Reduction Journal 2026 (in press). [doi: 10.1186/s12954-026-01512-z]
  12. Gordon AJ, Hatch MA, Kropp FB, Liebschutz JM, Mooney LJ, Cochran G. Twenty-five years of the NIDA clinical trials network and the future of addiction research. Journal of Substance Use & Addiction Research 2026: 210140 (in press). [doi: 10.1016/j.josat.2026.210140] PMID: 42893770
  13. Dawson D, Hall W, Goodwin I, Carlini BH, Lubman DI, Hammond D, Freeman TP, Lorenzetti V. Exploring THC labelling preferences to communicate the strength of cannabis products: Insights from U.S. consumers. International Journal of Drug Policy 2026;147:105076. [doi: 10.1016/j.drugpo.2025.105076] PMID: 41442927
  14. Cioffi C, Baloh J, Brunner M, Cheng H, DiFiore E, Davis AD, Fenstemark C, Fisher S, Finlayson R, Franz B, Franz D, Hosseini MA, Rains AN, Schmidt A, Smith C, Vest N, Hartzler B, CTN Implementation Strategies Workgroup. A scoping review of implementation strategies to reduce stigma toward people who use substances in healthcare settings. Journal of Substance Use and Addition Treatment 2026 (in press). [doi: 10.1016/j.josat.2026.210005] PMID: 42069061
  15. Owens, MD. Evaluation of the City of Seattle Ordinance 126896 on Controlled Substances: Final Report [to the Seattle Office of Inspector General]. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2025.
  16. Siebert SL, Owens MD, Folk JB, Moore KE. Criminal justice staff’s professional quality of life and interactions with justice-involved individuals: The moderating role of stigma. Deviant Behavior 2025;46(6):803-819. [doi: 10.1080/01639625.2024.2372419] PMID: 40519513
  17. Kellum LB, Carlini BH, Garrett S. Assessing Engagement in Cannabis Policy: A Survey of Washington State Elected Officials. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2025
  18. Hunnicut-Ferguson K, Stoner SA, Kable JA, Grant TM, Coles CD. Substance use and mental health symptoms in adults with prenatal alcohol exposure. Neurotoxicology Teratology 2025;109:107436. [doi: 10.1016/j.ntt.2025.107436] PMID: 40032207
  19. Garrett SB, Williams J, Carlini BH, Hammond D. Cannabis consumer patterns, adverse events, and cannabis risk beliefs: A latent profile analysis in WA State. Drug and Alcohol Dependence 2025;273:112728. [doi: 10.1016/j.drugalcdep.2025.112728]
  20. Hartzler B, Doig M, Cooke A, Kunkel L, Peng L, Stack E, Smith Payne K, McIlveen J, Korthuis PT. Training addiction professionals and peers to deliver contingency management via a coaching-to-criterion process: Results of a non-inferiority analysis. Substance Use & Addiction Journal 2025 (in press).